Manipulating pathway and growth factor interactions with heparan sulfate proteoglycans (HSPGs) could regulate hMSC neurogenesis, potentially offering functional neural stem cell transplants as AD treatments. This evidence concerns the gene CD44 and Alzheimer disease.